New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
17:55 EDTQCOR, MNKQuestcor's Acthar risks not included in Mallinckrodt's merger proxy, NYT says
Risks regarding the increase of adverse events related to Questcor's (QCOR) drug Acthar need to be considered by Mallinckrodt's (MNK) shareholders. Those risks were not included in last month's merger proxy, reports the New York Times. Reference Link
News For MNK;QCOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2015
11:25 EDTMNKMallinckrodt management to meet with Jefferies
Meetings to be held in Boston/New York on April 21-22 hosted by Jefferies.
07:41 EDTMNKEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
April 13, 2015
17:32 EDTMNKMallinckrodt says Questcor to pay $38M in proposed settlement
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use